Direct-acting antivirals (DAAs) have a positive effect on depression and cognitive function in patients with chronic hepatitis C

Depression, anxiety, neuroticism and results of neurocognitive tests: aBeck Depression Inventory; bAssessed by State-Trait Anxiety inventory (STAI); cEvaluated by Eysenck Personality Inventory (N/EPO-R); dSum of immediate recall from Trial-1 to Trial-5 in California Verbal Learning Test (CVLT); eRuff Figural Fluency Test (RFFT); fWisconsin Card Sorting Test (WCST) in 52 chronic hepatitis C patients before and after antiviral therapy. Patients with advanced liver disease were F3/F4 on the Metavir scale and patients with mild liver disease were F0-F3. Statistical analysis

Direct-acting antivirals (DAA) positively affect depression and cognitive function in patients with chronic hepatitis C Tomasz Pawłowski,  Marek Radkowski,  Karol Perlejewski ,  Bogna Szymańska,  Hanna Berak,  Andrzej Horban,  Tomasz LaskusPublished: April…

Go to contentDirect-acting antivirals (DAAs) have a positive effect on depression and cognitive function in patients with chronic hepatitis C